Sodium-Glucose Cotransporter 2 Inhibitor [EPC]

Sodium-Glucose Cotransporter 2 Inhibitor [EPC] was reported 109123 times

Drugs of the Sodium-Glucose Cotransporter 2 Inhibitor [EPC] class are most commonly taken among patients reporting these side effects:

# Drug class Count Frequency
0 CARDIOSPASM 404 0.7240
1 EUGLYCAEMIC DIABETIC KETOACIDOSIS 2909 0.7038
2 IMMUNISATION 257 0.5922
3 PALMOPLANTAR KERATODERMA 394 0.5434
4 MALIGNANT MEDIASTINAL NEOPLASM 58 0.5273
5 BALANITIS CANDIDA 50 0.3906
6 URINE KETONE BODY 55 0.3374
7 KETOSIS 348 0.3207
8 BLOOD KETONE BODY INCREASED 240 0.3073
9 URINARY TRACT CANDIDIASIS 58 0.3037
10 GENITAL INFECTION 99 0.3000
11 PERINEAL INFECTION 59 0.2980
12 KETOACIDOSIS 2150 0.2870
13 DIABETIC KETOSIS 109 0.2868
14 PRURITUS GENITAL 635 0.2694
15 EMPHYSEMATOUS PYELONEPHRITIS 48 0.2623
16 ACETONAEMIA 66 0.2619
17 BALANOPOSTHITIS 205 0.2494
18 KETONURIA 189 0.2322
19 DIABETIC KETOACIDOSIS 5298 0.2203
20 CATARRH 179 0.1980
21 ATRIAL TACHYCARDIA 416 0.1979
22 STEROID DEPENDENCE 172 0.1959
23 PHIMOSIS 141 0.1913
24 BLOOD KETONE BODY 65 0.1873
25 URINE KETONE BODY PRESENT 290 0.1837
26 SCROTAL ABSCESS 65 0.1720
27 GENITAL INFECTION FUNGAL 138 0.1671
28 GLUCOSE URINE PRESENT 191 0.1502
29 GLYCOSYLATED HAEMOGLOBIN ABNORMAL 176 0.1469
30 PERINEAL ABSCESS 57 0.1264
31 CAROTID ARTERY OCCLUSION 422 0.1156
32 NECROTISING FASCIITIS 407 0.1153
33 GENITAL SWELLING 76 0.1100
34 POLYCYTHAEMIA 223 0.1080
35 DIABETIC METABOLIC DECOMPENSATION 148 0.1066
36 N-TERMINAL PROHORMONE BRAIN NATRIURETIC PEPTIDE INCREASED 146 0.1039
37 BURNS SECOND DEGREE 180 0.1025
38 HEART FAILURE WITH REDUCED EJECTION FRACTION 54 0.1009
39 GLOMERULAR FILTRATION RATE INCREASED 82 0.0993
40 GENITAL ERYTHEMA 49 0.0988
41 GLYCOSYLATED HAEMOGLOBIN DECREASED 155 0.0962
42 SLEEP TERROR 399 0.0947
43 TENSION HEADACHE 402 0.0934
44 GLYCOSURIA 124 0.0917
45 URINARY TRACT INFECTION FUNGAL 51 0.0889
46 GASTROINTESTINAL HYPOMOTILITY 196 0.0869
47 GENITAL DISCOMFORT 47 0.0848
48 HYPERGLYCAEMIC HYPEROSMOLAR NONKETOTIC SYNDROME 92 0.0827
49 GLOMERULAR FILTRATION RATE ABNORMAL 115 0.0812
50 PERINEAL PAIN 58 0.0811
51 ORCHITIS 82 0.0762
52 CARDIAC AMYLOIDOSIS 83 0.0754
53 FUNGAL INFECTION 2458 0.0737
54 DILATED CARDIOMYOPATHY 74 0.0732
55 CARDIAC FAILURE CHRONIC 308 0.0722
56 MICROALBUMINURIA 54 0.0714
57 GLYCOSYLATED HAEMOGLOBIN INCREASED 1565 0.0619
58 GLOMERULAR FILTRATION RATE DECREASED 710 0.0577
59 VULVOVAGINAL PRURITUS 291 0.0574
60 VULVOVAGINAL CANDIDIASIS 77 0.0569
61 CAROTID ARTERIOSCLEROSIS 58 0.0562
62 IMPAIRED GASTRIC EMPTYING 765 0.0561
63 PRODUCT MONITORING ERROR 81 0.0561
64 GENITAL BURNING SENSATION 48 0.0554
65 VULVOVAGINAL MYCOTIC INFECTION 211 0.0536
66 PRERENAL FAILURE 75 0.0532
67 HYPOPNOEA 183 0.0527
68 GENITAL RASH 75 0.0525
69 ANION GAP INCREASED 70 0.0523
70 BRASH SYNDROME 73 0.0520
71 MARASMUS 79 0.0519
72 HYPOVOLAEMIA 281 0.0480
73 LEFT ATRIAL DILATATION 61 0.0478
74 FACIAL PAIN 421 0.0471
75 SYSTEMIC CANDIDA 118 0.0470
76 GENITAL PAIN 69 0.0467
77 UROSEPSIS 424 0.0459
78 HAEMATOCRIT INCREASED 104 0.0456
79 ALCOHOL POISONING 122 0.0455
80 TOE AMPUTATION 225 0.0443
81 GROIN ABSCESS 52 0.0441
82 DIABETIC FOOT 135 0.0441
83 PENILE SWELLING 53 0.0433
84 SUBARACHNOID HAEMORRHAGE 436 0.0428
85 BLOOD GLUCOSE ABNORMAL 781 0.0422
86 ABNORMAL LOSS OF WEIGHT 285 0.0418
87 AMPUTATION 52 0.0417
88 METABOLIC ACIDOSIS 1314 0.0410
89 VASCULITIS 477 0.0409
90 LACTIC ACIDOSIS 1316 0.0406
91 ACIDOSIS 310 0.0405
92 FOOT AMPUTATION 59 0.0405
93 OBSTRUCTIVE SLEEP APNOEA SYNDROME 59 0.0404
94 EPIDIDYMITIS 47 0.0404
95 POLYURIA 327 0.0399
96 HYPOGLYCAEMIC COMA 115 0.0399
97 HAEMOGLOBIN INCREASED 177 0.0388
98 DIABETES MELLITUS INADEQUATE CONTROL 666 0.0376
99 VENTRICULAR TACHYCARDIA 620 0.0375
100 PANCREATITIS NECROTISING 86 0.0374
101 BRONCHIECTASIS 248 0.0368
102 PERIPHERAL ARTERIAL OCCLUSIVE DISEASE 147 0.0360
103 CARDIAC VENTRICULAR THROMBOSIS 46 0.0356
104 EXTREMITY NECROSIS 62 0.0355
105 POLYDIPSIA 138 0.0349
106 PYELONEPHRITIS ACUTE 66 0.0336
107 BODY MASS INDEX INCREASED 45 0.0333
108 HYPERNATRAEMIA 166 0.0333
109 POLLAKIURIA 1388 0.0332
110 PROSTATITIS 97 0.0318
111 HYPERKALAEMIA 1108 0.0316
112 HYPERVOLAEMIA 156 0.0315
113 DIABETIC RETINOPATHY 105 0.0309
114 URINE OUTPUT INCREASED 80 0.0306
115 GANGRENE 179 0.0297
116 THIRST 530 0.0296
117 ANOSMIA 427 0.0295
118 INSULIN RESISTANCE 61 0.0293
119 BLOOD BICARBONATE DECREASED 55 0.0290
120 LEFT VENTRICULAR DYSFUNCTION 191 0.0285
121 CARDIAC FAILURE ACUTE 187 0.0280
122 PAROSMIA 204 0.0270
123 DIASTOLIC DYSFUNCTION 83 0.0269
124 PERICARDITIS 444 0.0264
125 URINE ABNORMALITY 120 0.0264
126 BLOOD IMMUNOGLOBULIN E INCREASED 62 0.0256
127 GINGIVAL PAIN 201 0.0252
128 EJECTION FRACTION DECREASED 392 0.0252
129 CARDIAC FAILURE 2021 0.0251
130 CARDIAC MURMUR 217 0.0251
131 LEG AMPUTATION 102 0.0247
132 BLOOD GLUCOSE FLUCTUATION 270 0.0246
133 HYPERLACTACIDAEMIA 66 0.0246
134 RHINITIS 196 0.0243
135 NEPHRITIS 81 0.0242
136 HYPOGLYCAEMIA 1174 0.0242
137 PYELONEPHRITIS 209 0.0241
138 ACUTE KIDNEY INJURY 3689 0.0241
139 DIABETIC NEPHROPATHY 52 0.0236
140 ORTHOPNOEA 75 0.0235
141 BLOOD GLUCOSE INCREASED 4409 0.0234
142 IMMUNE-MEDIATED MYOSITIS 64 0.0232
143 DIABETIC COMA 65 0.0232
144 DIABETIC NEUROPATHY 112 0.0226
145 RED BLOOD CELL COUNT INCREASED 62 0.0225
146 VENTRICULAR HYPOKINESIA 71 0.0221
147 CANDIDA INFECTION 368 0.0218
148 HYPERGLYCAEMIA 794 0.0218
149 HYPOVOLAEMIC SHOCK 103 0.0215
150 BLOOD CREATINE INCREASED 95 0.0214
151 PEMPHIGOID 161 0.0213
152 BLOOD LACTIC ACID INCREASED 112 0.0212
153 PHYSICAL DECONDITIONING 54 0.0210
154 CUTANEOUS VASCULITIS 76 0.0208
155 BLOOD CREATININE ABNORMAL 72 0.0208
156 ANAL ABSCESS 112 0.0208
157 RED CELL DISTRIBUTION WIDTH INCREASED 86 0.0207
158 MITRAL VALVE INCOMPETENCE 234 0.0207
159 CARDIAC OPERATION 176 0.0205
160 DIZZINESS POSTURAL 198 0.0204
161 URINE ODOUR ABNORMAL 120 0.0204
162 DEHYDRATION 2649 0.0198
163 MICTURITION URGENCY 224 0.0196
164 URINARY TRACT INFECTION BACTERIAL 49 0.0194
165 PANCREATITIS ACUTE 431 0.0192
166 BRAIN NATRIURETIC PEPTIDE INCREASED 59 0.0191
167 DIPLOPIA 490 0.0188
168 VULVOVAGINAL DISCOMFORT 83 0.0188
169 MUSCLE TWITCHING 428 0.0185
170 VITAMIN B12 DECREASED 53 0.0184
171 BLINDNESS 744 0.0182
172 TRANSIENT ISCHAEMIC ATTACK 613 0.0182
173 PERIPHERAL ISCHAEMIA 74 0.0181
174 TUBULOINTERSTITIAL NEPHRITIS 338 0.0180
175 TESTICULAR PAIN 56 0.0176
176 BLOOD GLUCOSE DECREASED 847 0.0176
177 VAGINAL INFECTION 83 0.0176
178 AORTIC ARTERIOSCLEROSIS 45 0.0175
179 CARDIAC DYSFUNCTION 65 0.0174
180 PROTEIN URINE PRESENT 87 0.0174
181 RENAL IMPAIRMENT 1459 0.0173
182 DYSURIA 638 0.0173
183 BLOOD POTASSIUM INCREASED 281 0.0173
184 ISCHAEMIC CARDIOMYOPATHY 53 0.0173
185 TROPONIN INCREASED 130 0.0171
186 LIP SWELLING 568 0.0170
187 BLOOD UREA INCREASED 282 0.0168
188 URINARY TRACT INFECTION 2865 0.0168
189 LEFT VENTRICULAR FAILURE 57 0.0165
190 DYSLIPIDAEMIA 84 0.0165
191 AORTIC STENOSIS 57 0.0164
192 HYPERURICAEMIA 67 0.0163
193 PAIN OF SKIN 437 0.0162
194 PROSTATOMEGALY 63 0.0160
195 PANCREATITIS 843 0.0159
196 IMPAIRED QUALITY OF LIFE 229 0.0159
197 LEFT VENTRICULAR HYPERTROPHY 68 0.0159
198 BLOOD PRESSURE SYSTOLIC DECREASED 72 0.0158
199 RENAL PAIN 167 0.0157
200 TRICUSPID VALVE INCOMPETENCE 124 0.0156
201 EYE PRURITUS 523 0.0155
202 RASH PAPULAR 344 0.0153
203 PENILE PAIN 46 0.0151
204 URINARY TRACT DISORDER 68 0.0151
205 RESPIRATORY ACIDOSIS 59 0.0150
206 THROAT CLEARING 56 0.0149
207 ATRIOVENTRICULAR BLOCK 115 0.0149
208 NEAR DEATH EXPERIENCE 49 0.0148
209 TINNITUS 680 0.0148
210 CORONARY ARTERY STENOSIS 74 0.0147
211 CONCOMITANT DISEASE AGGRAVATED 90 0.0146
212 NOCTURIA 177 0.0146
213 ABSCESS LIMB 62 0.0145
214 BLOOD URIC ACID INCREASED 84 0.0145
215 WEIGHT DECREASED 4031 0.0144
216 ANXIETY DISORDER 48 0.0144
217 ACUTE MYOCARDIAL INFARCTION 417 0.0141
218 ANGIOEDEMA 624 0.0141
219 ANAL INCONTINENCE 125 0.0139
220 PROTEINURIA 262 0.0138
221 BENIGN PROSTATIC HYPERPLASIA 71 0.0137
222 FUNGAL SKIN INFECTION 55 0.0136
223 ELECTROLYTE IMBALANCE 158 0.0136
224 VITAMIN B12 DEFICIENCY 55 0.0136
225 GASTROENTERITIS 198 0.0136
226 DIABETES MELLITUS 1025 0.0134
227 DEMENTIA 375 0.0134
228 OLIGURIA 83 0.0134
229 STAPHYLOCOCCAL BACTERAEMIA 58 0.0133
230 OPTIC ISCHAEMIC NEUROPATHY 51 0.0132
231 LIPASE INCREASED 100 0.0130
232 DUODENAL ULCER 92 0.0130
233 RENAL TUBULAR NECROSIS 127 0.0129
234 ERUCTATION 250 0.0129
235 BLOOD CREATININE INCREASED 842 0.0129
236 CEREBRAL INFARCTION 315 0.0129
237 ARTERIOSCLEROSIS CORONARY ARTERY 85 0.0128
238 THYROID MASS 49 0.0128
239 SKIN ULCER 330 0.0128
240 IRON DEFICIENCY 57 0.0127
241 TACHYPNOEA 172 0.0126
242 ARTERIOSCLEROSIS 119 0.0126
243 DYSPNOEA EXERTIONAL 475 0.0126
244 HYPOPHAGIA 321 0.0125
245 ATRIOVENTRICULAR BLOCK COMPLETE 84 0.0125
246 RENAL FUNCTION TEST ABNORMAL 58 0.0125
247 ATRIAL FIBRILLATION 1216 0.0125
248 HEPATIC CYTOLYSIS 159 0.0125
249 BLOOD PRESSURE DIASTOLIC DECREASED 92 0.0125
250 ORTHOSTATIC HYPOTENSION 217 0.0124
251 AORTIC VALVE INCOMPETENCE 53 0.0124
252 VULVOVAGINAL PAIN 60 0.0124
253 FLUID INTAKE REDUCED 62 0.0124
254 INFLAMMATORY MARKER INCREASED 61 0.0123
255 RALES 71 0.0122
256 HYPERTHYROIDISM 177 0.0122
257 HAEMATURIA 418 0.0122
258 CHOLECYSTITIS 145 0.0122
259 ALTERED STATE OF CONSCIOUSNESS 263 0.0121
260 IDIOPATHIC PULMONARY FIBROSIS 48 0.0121
261 HYPOTENSION 2405 0.0120
262 URINARY INCONTINENCE 355 0.0120
263 IRON DEFICIENCY ANAEMIA 110 0.0119
264 IMMUNE THROMBOCYTOPENIA 54 0.0118
265 CARDIOGENIC SHOCK 169 0.0118
266 VENTRICULAR EXTRASYSTOLES 122 0.0117
267 BLOOD TRIGLYCERIDES INCREASED 207 0.0117
268 NEPHROTIC SYNDROME 80 0.0117
269 RENAL DISORDER 543 0.0116
270 INTENTIONAL PRODUCT USE ISSUE 1020 0.0116
271 HYDRONEPHROSIS 87 0.0116
272 FREQUENT BOWEL MOVEMENTS 313 0.0116
273 COGNITIVE DISORDER 539 0.0115
274 ESCHERICHIA URINARY TRACT INFECTION 49 0.0115
275 CARDIOMYOPATHY 170 0.0115
276 CORONARY ARTERY BYPASS 66 0.0115
277 INFUSION SITE PAIN 146 0.0113
278 NECROSIS 63 0.0113
279 ILEUS 140 0.0113
280 COVID-19 PNEUMONIA 133 0.0113
281 SEASONAL ALLERGY 159 0.0112
282 HYPERVENTILATION 65 0.0112
283 COVID-19 1957 0.0111
284 ATRIAL FLUTTER 89 0.0111
285 DISTURBANCE IN ATTENTION 600 0.0111
286 SEPTIC SHOCK 482 0.0111
287 BLOOD PRESSURE DECREASED 732 0.0110
288 MALNUTRITION 122 0.0109
289 SEPSIS 1198 0.0107
290 HYPOACUSIS 462 0.0107
291 ANURIA 92 0.0107
292 HEPATIC STEATOSIS 199 0.0107
293 DERMATITIS BULLOUS 77 0.0106
294 OVERWEIGHT 57 0.0106
295 CARDIAC PACEMAKER INSERTION 63 0.0106
296 PANCREATIC DISORDER 52 0.0105
297 ERYSIPELAS 53 0.0105
298 SWOLLEN TONGUE 328 0.0105
299 MEDICATION ERROR 583 0.0105
300 HYPOMAGNESAEMIA 146 0.0105
301 TYPE 2 DIABETES MELLITUS 353 0.0105
302 ANGINA UNSTABLE 68 0.0105
303 BLOOD PRESSURE SYSTOLIC INCREASED 204 0.0104
304 VENTRICULAR FIBRILLATION 116 0.0104
305 HAEMOGLOBIN ABNORMAL 67 0.0104
306 SKIN ABRASION 49 0.0104
307 ISCHAEMIC STROKE 185 0.0104
308 VULVOVAGINAL BURNING SENSATION 63 0.0103
309 BLOOD MAGNESIUM DECREASED 89 0.0103
310 PALPITATIONS 1203 0.0103
311 WEIGHT FLUCTUATION 107 0.0102
312 ACCIDENTAL OVERDOSE 374 0.0102
313 INCONTINENCE 108 0.0102
314 CHOLECYSTITIS ACUTE 57 0.0100
315 ADRENAL INSUFFICIENCY 122 0.0100
316 HYPERLIPIDAEMIA 120 0.0100
317 URINARY RETENTION 335 0.0100
318 MYOCARDIAL INFARCTION 1746 0.0100
319 HYPERTRIGLYCERIDAEMIA 58 0.0099
320 ABDOMINAL DISCOMFORT 1658 0.0099
321 ILLNESS 1017 0.0099
322 CARDIOMEGALY 121 0.0098
323 HUNGER 137 0.0098
324 ENERGY INCREASED 58 0.0098
325 RENAL CYST 78 0.0098
326 LOW DENSITY LIPOPROTEIN INCREASED 76 0.0098
327 BLOOD PRESSURE ABNORMAL 195 0.0098
328 IMPAIRED WORK ABILITY 209 0.0098
329 INABILITY TO AFFORD MEDICATION 97 0.0098
330 CARDIAC FLUTTER 63 0.0097
331 AMNESIA 628 0.0096
332 PRODUCT RESIDUE PRESENT 52 0.0096
333 CORONARY ARTERY DISEASE 292 0.0096
334 TACHYCARDIA 856 0.0096
335 MUSCLE ATROPHY 122 0.0096
336 INFUSION SITE ERYTHEMA 81 0.0096
337 FEMORAL NECK FRACTURE 49 0.0095
338 EXERCISE TOLERANCE DECREASED 55 0.0095
339 ARTERIAL OCCLUSIVE DISEASE 75 0.0095
340 BLOOD URINE PRESENT 181 0.0095
341 PRESYNCOPE 231 0.0095
342 HEART RATE INCREASED 937 0.0094
343 RHABDOMYOLYSIS 394 0.0094
344 CHRONIC KIDNEY DISEASE 717 0.0094
345 ANGINA PECTORIS 270 0.0094
346 MELAENA 207 0.0094
347 HYPOKALAEMIA 434 0.0094
348 PERIPHERAL SWELLING 1440 0.0093
349 CYSTITIS 297 0.0093
350 FOOD CRAVING 49 0.0093
351 GOUT 167 0.0093
352 GLUCOSE TOLERANCE IMPAIRED 55 0.0093
353 TYPE 1 DIABETES MELLITUS 56 0.0093
354 CEREBROVASCULAR ACCIDENT 1574 0.0093
355 FLANK PAIN 87 0.0093
356 BLOOD IRON DECREASED 110 0.0093
357 DECREASED APPETITE 2153 0.0093
358 LIMB INJURY 251 0.0092
359 OSTEOMYELITIS 167 0.0092
360 SHOCK 212 0.0092
361 INFARCTION 63 0.0092
362 PULMONARY CONGESTION 121 0.0092
363 FULL BLOOD COUNT ABNORMAL 97 0.0092
364 VISUAL IMPAIRMENT 1130 0.0091
365 CORONARY ARTERY OCCLUSION 125 0.0091
366 GROIN PAIN 80 0.0091
367 VOMITING 4280 0.0091
368 OBESITY 145 0.0091
369 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 436 0.0091
370 ACUTE CORONARY SYNDROME 75 0.0090
371 HALLUCINATION 682 0.0090
372 FOOD POISONING 48 0.0090
373 PULMONARY HYPERTENSION 186 0.0089
374 ARRHYTHMIA 422 0.0089
375 PULMONARY OEDEMA 398 0.0089
376 HAEMATOCHEZIA 489 0.0089
377 URINE OUTPUT DECREASED 77 0.0088
378 MUSCULAR WEAKNESS 997 0.0088
379 ACUTE RESPIRATORY FAILURE 168 0.0087
380 FLUID RETENTION 442 0.0087
381 C-REACTIVE PROTEIN INCREASED 316 0.0087
382 LOCALISED INFECTION 210 0.0087
383 ESCHERICHIA INFECTION 71 0.0086
384 BRAIN FOG 135 0.0086
385 HYPONATRAEMIA 485 0.0086
386 DIZZINESS 4291 0.0086
387 BLOOD ALBUMIN DECREASED 68 0.0086
388 JOINT EFFUSION 59 0.0085
389 PRODUCT PRESCRIBING ERROR 203 0.0085
390 CARDIAC DISORDER 797 0.0085
391 DEAFNESS 222 0.0085
392 PRODUCT ADMINISTRATION INTERRUPTED 66 0.0084
393 CHOLELITHIASIS 275 0.0084
394 TASTE DISORDER 170 0.0084
395 RECTAL HAEMORRHAGE 359 0.0083
396 ABDOMINAL PAIN UPPER 1719 0.0083
397 SLEEP APNOEA SYNDROME 159 0.0083
398 CORONAVIRUS INFECTION 55 0.0083
399 FEEDING DISORDER 168 0.0083
400 HEPATIC CIRRHOSIS 155 0.0082
401 RENAL FAILURE 1095 0.0082
402 SHOCK HAEMORRHAGIC 67 0.0082
403 DECUBITUS ULCER 67 0.0082
404 CARDIAC FAILURE CONGESTIVE 657 0.0082
405 ELECTROCARDIOGRAM ABNORMAL 64 0.0081
406 HYPERHIDROSIS 1045 0.0081
407 INFUSION SITE SWELLING 51 0.0081
408 GENERALISED OEDEMA 100 0.0081
409 MIGRAINE 769 0.0080
410 BLOOD POTASSIUM DECREASED 242 0.0080
411 LEUKOCYTOSIS 145 0.0080
412 RESPIRATORY RATE INCREASED 71 0.0080
413 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 62 0.0080
414 AGRANULOCYTOSIS 148 0.0080
415 FLATULENCE 450 0.0079
416 HAEMODYNAMIC INSTABILITY 60 0.0079
417 DRUG INTERACTION 1247 0.0079
418 APPETITE DISORDER 52 0.0078
419 CHEST PAIN 1449 0.0078
420 HICCUPS 64 0.0078
421 OXYGEN SATURATION DECREASED 437 0.0078
422 DIARRHOEA 5019 0.0078
423 INTENTIONAL PRODUCT MISUSE 680 0.0078
424 KIDNEY INFECTION 152 0.0077
425 BLOOD SODIUM DECREASED 146 0.0077
426 OEDEMA 420 0.0077
427 HYPOPHOSPHATAEMIA 57 0.0077
428 NIGHTMARE 266 0.0077
429 VERTIGO 467 0.0077
430 PERIPHERAL COLDNESS 105 0.0076
431 MYOCARDIAL ISCHAEMIA 87 0.0076
432 CATARACT 453 0.0076
433 CHOLANGITIS 47 0.0076
434 HYPOCALCAEMIA 143 0.0075
435 DEATH 6506 0.0075
436 OROPHARYNGEAL DISCOMFORT 68 0.0075
437 MULTIPLE ORGAN DYSFUNCTION SYNDROME 213 0.0075
438 CONSTIPATION 1634 0.0075
439 COLD SWEAT 132 0.0075
440 CELLULITIS 377 0.0075
441 ACCIDENTAL UNDERDOSE 107 0.0074
442 MEMORY IMPAIRMENT 1020 0.0074
443 HEART RATE DECREASED 260 0.0074
444 DERMATITIS ALLERGIC 93 0.0074
445 NEPHROPATHY 69 0.0074
446 ABDOMINAL PAIN 1717 0.0074
447 AUTOIMMUNE HEPATITIS 51 0.0073
448 INCREASED APPETITE 140 0.0073
449 OEDEMA PERIPHERAL 892 0.0073
450 BOWEL MOVEMENT IRREGULARITY 56 0.0073
451 BLOOD THYROID STIMULATING HORMONE INCREASED 67 0.0073
452 VITAMIN D DEFICIENCY 71 0.0073
453 BLOOD PRESSURE FLUCTUATION 174 0.0072
454 ECZEMA 378 0.0072
455 SYNCOPE 720 0.0072
456 DYSPNOEA 4064 0.0072
457 MYOPATHY 62 0.0072
458 DRY MOUTH 582 0.0072
459 NEPHROLITHIASIS 329 0.0072
460 CIRCULATORY COLLAPSE 122 0.0072
461 COLITIS ULCERATIVE 320 0.0072
462 PROCTALGIA 46 0.0071
463 RIGHT VENTRICULAR FAILURE 50 0.0071
464 ONYCHOCLASIS 49 0.0071
465 WRONG PRODUCT ADMINISTERED 48 0.0071
466 SKIN LACERATION 77 0.0071
467 DYSPEPSIA 687 0.0070
468 INTESTINAL OBSTRUCTION 262 0.0069
469 HEART RATE IRREGULAR 157 0.0069
470 ORAL CANDIDIASIS 91 0.0069
471 ERECTILE DYSFUNCTION 177 0.0069
472 TORSADE DE POINTES 54 0.0069
473 ASPHYXIA 56 0.0069
474 NAUSEA 5426 0.0068
475 CONCUSSION 53 0.0068
476 SCIATICA 109 0.0068
477 BACTERAEMIA 81 0.0068
478 BACK PAIN 1582 0.0068
479 PARKINSONISM 66 0.0068
480 ABDOMINAL DISTENSION 705 0.0067
481 SPINAL PAIN 79 0.0067
482 GENERAL PHYSICAL HEALTH DETERIORATION 779 0.0067
483 PRODUCTIVE COUGH 321 0.0067
484 PULMONARY MASS 100 0.0067
485 PNEUMONIA ASPIRATION 167 0.0067
486 LARGE INTESTINE POLYP 46 0.0066
487 SYSTEMIC LUPUS ERYTHEMATOSUS 235 0.0066
488 NERVE COMPRESSION 61 0.0066
489 EXTRA DOSE ADMINISTERED 267 0.0066
490 DECREASED ACTIVITY 71 0.0066
491 ASTHENIA 2474 0.0066
492 GASTRITIS 173 0.0066
493 FACIAL PARALYSIS 56 0.0066
494 ARTHRITIS 516 0.0066
495 GAIT INABILITY 219 0.0065
496 DRUG ERUPTION 116 0.0065
497 BLADDER DISORDER 65 0.0065
498 CONFUSIONAL STATE 1057 0.0065
499 CONTRAINDICATED PRODUCT ADMINISTERED 198 0.0065
500 POST PROCEDURAL INFECTION 53 0.0065
501 DRUG-INDUCED LIVER INJURY 204 0.0065
502 FAECES SOFT 47 0.0065
503 STENT PLACEMENT 52 0.0064
504 COLON CANCER 96 0.0064
505 MYASTHENIA GRAVIS 52 0.0064
506 FALL 2136 0.0064
507 SPINAL OPERATION 79 0.0064
508 THERAPY CHANGE 63 0.0064
509 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 1151 0.0064
510 PANCREATIC CARCINOMA 183 0.0063
511 PERICARDIAL EFFUSION 146 0.0063
512 UPPER GASTROINTESTINAL HAEMORRHAGE 106 0.0063
513 CYST 78 0.0063
514 BRAIN INJURY 63 0.0063
515 LETHARGY 361 0.0063
516 BLOOD CALCIUM INCREASED 55 0.0063
517 HYPOKINESIA 91 0.0063
518 COUGH 1754 0.0062
519 EATING DISORDER 133 0.0062
520 OCULAR DISCOMFORT 70 0.0062
521 PNEUMONIA BACTERIAL 57 0.0062
522 BRADYCARDIA 329 0.0062
523 DRY THROAT 63 0.0062
524 POST PROCEDURAL COMPLICATION 119 0.0062
525 HYPERCALCAEMIA 76 0.0061
526 LIVER INJURY 151 0.0061
527 MULTIPLE ALLERGIES 48 0.0061
528 SPUTUM DISCOLOURED 58 0.0061
529 POLYNEUROPATHY 73 0.0061
530 GASTROINTESTINAL DISORDER 546 0.0061
531 MALAISE 2672 0.0061
532 RETINAL DETACHMENT 56 0.0061
533 BLOOD PRESSURE INCREASED 929 0.0061
534 EMPHYSEMA 61 0.0060
535 JOINT INJURY 129 0.0060
536 MYOCARDITIS 69 0.0060
537 SMALL INTESTINAL OBSTRUCTION 74 0.0060
538 GASTROINTESTINAL PAIN 66 0.0060
539 GASTRIC ULCER 114 0.0060
540 TOXIC SKIN ERUPTION 60 0.0060
541 CHOLESTASIS 114 0.0059
542 PELVIC FRACTURE 46 0.0059
543 PRURITUS 2266 0.0059
544 BACTERIAL INFECTION 110 0.0059
545 DRY SKIN 785 0.0059
546 EOSINOPHILIA 103 0.0059
547 LOSS OF CONSCIOUSNESS 751 0.0059
548 HAEMORRHOIDS 114 0.0058
549 PLEURAL EFFUSION 355 0.0058
550 DELIRIUM 201 0.0058
551 RHINORRHOEA 374 0.0058
552 LIMB DISCOMFORT 179 0.0058
553 EPISTAXIS 432 0.0058
554 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 51 0.0058
555 ABSCESS 92 0.0058
556 HYPERTENSION 1218 0.0057
557 BLINDNESS UNILATERAL 81 0.0057
558 FATIGUE 4462 0.0057
559 PHARYNGEAL SWELLING 56 0.0057
560 PRESCRIBED UNDERDOSE 114 0.0057
561 CHROMATURIA 129 0.0057
562 GLAUCOMA 110 0.0057
563 ACUTE RESPIRATORY DISTRESS SYNDROME 101 0.0057
564 THERAPY INTERRUPTED 408 0.0057
565 NEOPLASM MALIGNANT 380 0.0057
566 GASTROINTESTINAL INFECTION 51 0.0057
567 INTENTIONAL DOSE OMISSION 162 0.0057
568 RETCHING 121 0.0057
569 CHEST DISCOMFORT 581 0.0057
570 GASTROOESOPHAGEAL REFLUX DISEASE 456 0.0057
571 RASH MACULO-PAPULAR 126 0.0057
572 DEEP VEIN THROMBOSIS 368 0.0057
573 SUBDURAL HAEMATOMA 81 0.0057
574 FEELING ABNORMAL 1352 0.0056
575 BLOOD CHOLESTEROL INCREASED 263 0.0056
576 RIB FRACTURE 116 0.0056
577 MUSCULOSKELETAL DISCOMFORT 97 0.0056
578 HEAD INJURY 178 0.0056
579 INSURANCE ISSUE 86 0.0056
580 ABNORMAL FAECES 46 0.0056
581 GASTROENTERITIS VIRAL 101 0.0056
582 APHONIA 78 0.0056
583 SLUGGISHNESS 57 0.0056
584 POOR QUALITY SLEEP 120 0.0056
585 MYOSITIS 50 0.0056
586 ASPIRATION 61 0.0056
587 TENDERNESS 58 0.0056
588 WOUND 154 0.0055
589 POOR VENOUS ACCESS 57 0.0055
590 DRUG LEVEL INCREASED 91 0.0055
591 HAEMOLYTIC ANAEMIA 49 0.0055
592 AGEUSIA 136 0.0054
593 ROTATOR CUFF SYNDROME 70 0.0054
594 MACULAR DEGENERATION 65 0.0054
595 OSTEOARTHRITIS 230 0.0054
596 HYPOXIA 191 0.0054
597 ULCER 86 0.0054
598 WEIGHT INCREASED 1207 0.0054
599 PULMONARY EMBOLISM 512 0.0054
600 PNEUMONIA 1739 0.0054
601 HIP FRACTURE 172 0.0053
602 PRODUCT DOSE OMISSION ISSUE 1568 0.0053
603 NASAL CONGESTION 313 0.0053
604 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 137 0.0053
605 PULMONARY ARTERIAL HYPERTENSION 77 0.0053
606 CARDIAC ARREST 438 0.0053
607 BACK DISORDER 86 0.0053
608 CARPAL TUNNEL SYNDROME 74 0.0053
609 CHOLECYSTECTOMY 60 0.0052
610 PROSTATIC SPECIFIC ANTIGEN INCREASED 72 0.0052
611 OESOPHAGITIS 57 0.0052
612 THROAT IRRITATION 234 0.0052
613 HYPERTENSIVE CRISIS 58 0.0052
614 PRODUCT ADMINISTRATION ERROR 105 0.0052
615 HIATUS HERNIA 67 0.0052
616 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 270 0.0052
617 DYSGEUSIA 384 0.0052
618 HYPOTHYROIDISM 165 0.0052
619 FAECES DISCOLOURED 112 0.0052
620 INJECTION SITE MASS 191 0.0052
621 HEPATITIS 132 0.0052
622 HOT FLUSH 388 0.0051
623 BLOOD CREATINE PHOSPHOKINASE INCREASED 148 0.0051
624 THERAPEUTIC RESPONSE UNEXPECTED 230 0.0051
625 SCRATCH 54 0.0051
626 ARTHRALGIA 2125 0.0051
627 TENDONITIS 79 0.0051
628 DERMATITIS CONTACT 58 0.0051
629 PRODUCT DOSE OMISSION IN ERROR 144 0.0051
630 PAIN IN EXTREMITY 1494 0.0051
631 NEUROPATHY PERIPHERAL 480 0.0050
632 OFF LABEL USE 4406 0.0050
633 APPENDICITIS 47 0.0050
634 UPPER LIMB FRACTURE 100 0.0050
635 DIVERTICULITIS 139 0.0050
636 SUPRAVENTRICULAR TACHYCARDIA 48 0.0050
637 SOMNOLENCE 1009 0.0050
638 SARS-COV-2 TEST POSITIVE 66 0.0050
639 MUSCULOSKELETAL CHEST PAIN 77 0.0050
640 BACK INJURY 54 0.0050
641 EYE PAIN 280 0.0050
642 ADVERSE DRUG REACTION 445 0.0049
643 HAEMATOCRIT DECREASED 98 0.0049
644 PYREXIA 1708 0.0049
645 SURGERY 289 0.0049
646 DEPRESSED LEVEL OF CONSCIOUSNESS 195 0.0049
647 SKIN DISORDER 164 0.0049
648 HAEMATOMA 127 0.0049
649 WHITE BLOOD CELL COUNT INCREASED 188 0.0049
650 SWELLING FACE 318 0.0049
651 HEADACHE 3060 0.0049
652 MUSCLE TIGHTNESS 79 0.0049
653 SINUS BRADYCARDIA 47 0.0049
654 SKIN HAEMORRHAGE 72 0.0049
655 RESPIRATORY TRACT CONGESTION 77 0.0048
656 MYALGIA 821 0.0048
657 FEELING COLD 134 0.0048
658 VISION BLURRED 660 0.0048
659 KNEE OPERATION 47 0.0048
660 PRODUCT ODOUR ABNORMAL 50 0.0048
661 PRODUCT PRESCRIBING ISSUE 104 0.0048
662 NERVE INJURY 53 0.0048
663 CARDIOVASCULAR DISORDER 121 0.0048
664 EYE SWELLING 177 0.0048
665 THERAPY CESSATION 243 0.0047
666 HAEMOPTYSIS 132 0.0047
667 HYPERBILIRUBINAEMIA 49 0.0047
668 INSOMNIA 1253 0.0047
669 PRODUCT USE COMPLAINT 74 0.0047
670 DYSSTASIA 137 0.0047
671 INITIAL INSOMNIA 48 0.0047
672 BODY TEMPERATURE DECREASED 46 0.0047
673 ANKLE FRACTURE 72 0.0046
674 MOBILITY DECREASED 334 0.0046
675 GAMMA-GLUTAMYLTRANSFERASE INCREASED 103 0.0046
676 VAGINAL DISCHARGE 47 0.0046
677 INFLUENZA 518 0.0046
678 HYPOTHERMIA 47 0.0046
679 DYSPHAGIA 440 0.0046
680 HEPATIC FUNCTION ABNORMAL 173 0.0046
681 ANAEMIA 884 0.0046
682 ABDOMINAL PAIN LOWER 117 0.0046
683 CEREBRAL HAEMORRHAGE 165 0.0046
684 EYE INFECTION 52 0.0046
685 SINUS DISORDER 91 0.0046
686 INFECTION 665 0.0046
687 DISORIENTATION 182 0.0046
688 PRODUCT DISPENSING ERROR 100 0.0046
689 LUNG DISORDER 225 0.0046
690 SLEEP DISORDER 323 0.0046
691 HAEMATEMESIS 116 0.0046
692 BEDRIDDEN 60 0.0046
693 PNEUMONITIS 124 0.0045
694 ALOPECIA 893 0.0045
695 DRUG EFFECT LESS THAN EXPECTED 67 0.0045
696 THERAPY NON-RESPONDER 203 0.0045
697 GAIT DISTURBANCE 860 0.0045
698 LOWER LIMB FRACTURE 86 0.0045
699 TOOTHACHE 81 0.0045
700 LIVER FUNCTION TEST INCREASED 96 0.0045
701 INTERSTITIAL LUNG DISEASE 216 0.0045
702 HERNIA 86 0.0044
703 PALLOR 121 0.0044
704 TREATMENT NONCOMPLIANCE 243 0.0044
705 RASH 1935 0.0044
706 KNEE ARTHROPLASTY 93 0.0044
707 RESPIRATORY FAILURE 321 0.0044
708 CONDITION AGGRAVATED 1338 0.0044
709 SKIN FISSURES 86 0.0044
710 OROPHARYNGEAL PAIN 407 0.0044
711 MUSCLE SPASMS 806 0.0044
712 SINUS TACHYCARDIA 62 0.0044
713 DYSPHONIA 255 0.0044
714 BASAL CELL CARCINOMA 68 0.0044
715 ACCIDENT 52 0.0044
716 JAUNDICE 117 0.0043
717 CLOSTRIDIUM DIFFICILE COLITIS 46 0.0043
718 RED BLOOD CELL COUNT DECREASED 124 0.0043
719 APATHY 63 0.0043
720 WHEEZING 255 0.0043
721 PARAESTHESIA ORAL 62 0.0043
722 BALANCE DISORDER 369 0.0043
723 RESPIRATORY TRACT INFECTION 111 0.0043
724 PRODUCT USE ISSUE 795 0.0042
725 PNEUMOTHORAX 67 0.0042
726 UNRESPONSIVE TO STIMULI 109 0.0042
727 COLITIS 160 0.0042
728 PLATELET COUNT INCREASED 55 0.0042
729 DISCOMFORT 257 0.0042
730 APHASIA 127 0.0042
731 INTERNAL HAEMORRHAGE 48 0.0042
732 WOUND INFECTION 46 0.0042
733 FEELING JITTERY 80 0.0042
734 NEURALGIA 102 0.0042
735 LIVER DISORDER 186 0.0042
736 INJECTION SITE HAEMORRHAGE 334 0.0042
737 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 71 0.0042
738 COMA 198 0.0042
739 SECRETION DISCHARGE 52 0.0041
740 HEPATIC ENZYME INCREASED 283 0.0041
741 INFLAMMATION 214 0.0041
742 SINUS CONGESTION 56 0.0041
743 LOWER RESPIRATORY TRACT INFECTION 188 0.0041
744 BLOOD TEST ABNORMAL 58 0.0041
745 DEPRESSED MOOD 218 0.0041
746 EYE HAEMORRHAGE 55 0.0041
747 SWELLING 384 0.0041
748 RASH PRURITIC 222 0.0041
749 DEVICE MECHANICAL ISSUE 56 0.0041
750 HYPERSOMNIA 116 0.0040
751 DISABILITY 80 0.0040
752 THERAPY PARTIAL RESPONDER 63 0.0040
753 EYE DISORDER 132 0.0040
754 SNEEZING 90 0.0040
755 TREMOR 666 0.0040
756 FOOT FRACTURE 76 0.0040
757 RASH MACULAR 140 0.0040
758 ANXIETY 1139 0.0040
759 ALANINE AMINOTRANSFERASE INCREASED 245 0.0040
760 LABORATORY TEST ABNORMAL 117 0.0040
761 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 802 0.0040
762 THYROID DISORDER 61 0.0040
763 PAIN IN JAW 112 0.0039
764 SPEECH DISORDER 207 0.0039
765 DRUG INTOLERANCE 381 0.0039
766 LACRIMATION INCREASED 119 0.0039
767 JOINT SWELLING 475 0.0039
768 HALLUCINATION, VISUAL 83 0.0039
769 INCORRECT DOSE ADMINISTERED BY DEVICE 103 0.0039
770 DEVICE LEAKAGE 170 0.0039
771 ANAPHYLACTIC SHOCK 101 0.0039
772 FRACTURE 74 0.0039
773 BLISTER 219 0.0039
774 PAIN 2386 0.0039
775 HYPOAESTHESIA 581 0.0039
776 DEPRESSION 880 0.0039
777 NASOPHARYNGITIS 707 0.0038
778 SKIN LESION 105 0.0038
779 ROAD TRAFFIC ACCIDENT 160 0.0038
780 CHILLS 448 0.0038
781 NIGHT SWEATS 123 0.0038
782 QUALITY OF LIFE DECREASED 51 0.0038
783 BLOOD ALKALINE PHOSPHATASE INCREASED 94 0.0038
784 HEMIPARESIS 64 0.0038
785 PRODUCT AVAILABILITY ISSUE 86 0.0038
786 THROMBOSIS 303 0.0038
787 VIRAL INFECTION 125 0.0038
788 MIDDLE INSOMNIA 70 0.0037
789 LIVER FUNCTION TEST ABNORMAL 109 0.0037
790 NECK PAIN 209 0.0037
791 MOVEMENT DISORDER 120 0.0037
792 RENAL INJURY 111 0.0037
793 HAEMOGLOBIN DECREASED 383 0.0037
794 ELECTROCARDIOGRAM QT PROLONGED 133 0.0037
795 INCORRECT PRODUCT ADMINISTRATION DURATION 80 0.0037
796 CYTOKINE RELEASE SYNDROME 74 0.0037
797 SKIN EXFOLIATION 311 0.0037
798 ORAL PAIN 82 0.0037
799 BRONCHITIS 271 0.0037
800 ANAPHYLACTIC REACTION 202 0.0037
801 PLATELET COUNT DECREASED 388 0.0036
802 IMPAIRED HEALING 119 0.0036
803 CHOKING 70 0.0036
804 PRODUCT USE IN UNAPPROVED INDICATION 886 0.0036
805 CONTUSION 344 0.0036
806 UPPER RESPIRATORY TRACT INFECTION 165 0.0036
807 SKIN DISCOLOURATION 164 0.0036
808 INTERVERTEBRAL DISC PROTRUSION 78 0.0036
809 DEVICE OCCLUSION 50 0.0035
810 ASTHMA 400 0.0035
811 GALLBLADDER DISORDER 63 0.0035
812 DIALYSIS 50 0.0035
813 ACUTE HEPATIC FAILURE 48 0.0035
814 SPINAL FRACTURE 70 0.0035
815 PARALYSIS 50 0.0035
816 DYSARTHRIA 131 0.0035
817 THROAT TIGHTNESS 94 0.0035
818 INCORRECT DOSE ADMINISTERED 792 0.0035
819 LYMPHOCYTE COUNT DECREASED 61 0.0034
820 HEAD DISCOMFORT 61 0.0034
821 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 59 0.0034
822 NEEDLE ISSUE 100 0.0034
823 BODY TEMPERATURE INCREASED 70 0.0034
824 INJECTION SITE BRUISING 273 0.0034
825 DISEASE RECURRENCE 162 0.0034
826 STAPHYLOCOCCAL INFECTION 112 0.0034
827 ORAL DISCOMFORT 47 0.0034
828 PSORIATIC ARTHROPATHY 137 0.0034
829 MOOD ALTERED 92 0.0034
830 NERVOUSNESS 176 0.0034
831 GASTROINTESTINAL HAEMORRHAGE 281 0.0034
832 HERPES ZOSTER 193 0.0034
833 MENTAL STATUS CHANGES 93 0.0033
834 END STAGE RENAL DISEASE 61 0.0033
835 RESPIRATORY DISORDER 100 0.0033
836 FIBROMYALGIA 81 0.0033
837 BURNING SENSATION 233 0.0033
838 SENSORY DISTURBANCE 53 0.0033
839 PHOTOPHOBIA 62 0.0033
840 BLOOD BILIRUBIN INCREASED 89 0.0033
841 PULMONARY FIBROSIS 63 0.0033
842 UNDERDOSE 239 0.0033
843 HIP ARTHROPLASTY 50 0.0033
844 FEELING HOT 199 0.0032
845 THROMBOCYTOPENIA 363 0.0032
846 CYANOSIS 51 0.0032
847 FEMUR FRACTURE 100 0.0032
848 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 229 0.0032
849 SINUSITIS 328 0.0032
850 THERAPEUTIC RESPONSE SHORTENED 106 0.0032
851 PSORIASIS 416 0.0032
852 HYPOAESTHESIA ORAL 48 0.0032
853 RASH ERYTHEMATOUS 152 0.0032
854 PANCYTOPENIA 177 0.0032
855 CLOSTRIDIUM DIFFICILE INFECTION 69 0.0032
856 SCAR 54 0.0032
857 PROCEDURAL PAIN 87 0.0031
858 MENTAL IMPAIRMENT 76 0.0031
859 RESTLESS LEGS SYNDROME 57 0.0031
860 DEVICE RELATED INFECTION 48 0.0031
861 DRY EYE 155 0.0031
862 DEVICE FAILURE 47 0.0031
863 URTICARIA 516 0.0031
864 ILL-DEFINED DISORDER 187 0.0031
865 ASCITES 90 0.0031
866 MUSCULOSKELETAL STIFFNESS 267 0.0030
867 EYE IRRITATION 172 0.0030
868 OCULAR HYPERAEMIA 141 0.0030
869 FACE OEDEMA 50 0.0030
870 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 138 0.0030
871 SEIZURE 341 0.0029
872 HYPERSENSITIVITY 547 0.0029
873 ASPARTATE AMINOTRANSFERASE INCREASED 156 0.0029
874 ERYTHEMA 602 0.0029
875 TRANSAMINASES INCREASED 65 0.0029
876 LYMPHADENOPATHY 103 0.0029
877 INJECTION SITE PRURITUS 194 0.0029
878 PRODUCT PHYSICAL ISSUE 58 0.0029
879 DERMATITIS 60 0.0029
880 ENCEPHALOPATHY 70 0.0028
881 METASTASES TO LIVER 50 0.0028
882 INJECTION SITE PAIN 871 0.0028
883 JOINT STIFFNESS 74 0.0028
884 PSYCHOTIC DISORDER 83 0.0028
885 HEPATIC FAILURE 84 0.0028
886 OSTEOPOROSIS 114 0.0028
887 EAR INFECTION 72 0.0027
888 LUNG NEOPLASM MALIGNANT 110 0.0027
889 ARTHROPATHY 148 0.0027
890 SYNOVITIS 48 0.0027
891 TOOTH DISORDER 59 0.0027
892 VAGINAL HAEMORRHAGE 115 0.0026
893 SUICIDAL IDEATION 241 0.0026
894 EAR PAIN 51 0.0026
895 HOSPITALISATION 403 0.0026
896 MOUTH ULCERATION 55 0.0026
897 PARAESTHESIA 410 0.0026
898 GASTRIC DISORDER 89 0.0026
899 PELVIC PAIN 47 0.0026
900 THINKING ABNORMAL 48 0.0026
901 RESPIRATORY DISTRESS 71 0.0026
902 BONE PAIN 150 0.0026
903 BLADDER CANCER 150 0.0025
904 INJECTION SITE WARMTH 52 0.0025
905 SKIN CANCER 54 0.0025
906 DRUG INEFFECTIVE 3303 0.0025
907 FEBRILE NEUTROPENIA 164 0.0025
908 IRRITABLE BOWEL SYNDROME 53 0.0025
909 PANIC ATTACK 90 0.0025
910 HAEMORRHAGE 256 0.0024
911 DEVICE DELIVERY SYSTEM ISSUE 67 0.0024
912 INTENTIONAL OVERDOSE 155 0.0024
913 FLUSHING 245 0.0024
914 DEVICE ISSUE 216 0.0024
915 INFLUENZA LIKE ILLNESS 197 0.0024
916 RESTLESSNESS 87 0.0024
917 MENTAL DISORDER 102 0.0023
918 TOXICITY TO VARIOUS AGENTS 392 0.0023
919 DEVICE MALFUNCTION 163 0.0023
920 HEPATOTOXICITY 51 0.0023
921 DYSKINESIA 93 0.0023
922 NERVOUS SYSTEM DISORDER 70 0.0022
923 TOOTH LOSS 46 0.0022
924 THERAPEUTIC PRODUCT EFFECT DECREASED 99 0.0022
925 EPILEPSY 67 0.0022
926 RHEUMATOID ARTHRITIS 245 0.0022
927 CARDIO-RESPIRATORY ARREST 90 0.0022
928 MUCOSAL INFLAMMATION 56 0.0021
929 MOOD SWINGS 68 0.0021
930 EXPIRED PRODUCT ADMINISTERED 70 0.0021
931 INTERNATIONAL NORMALISED RATIO INCREASED 60 0.0021
932 ABNORMAL DREAMS 57 0.0021
933 INJECTION SITE SWELLING 158 0.0021
934 INJECTION SITE URTICARIA 50 0.0020
935 INFUSION RELATED REACTION 135 0.0020
936 NEUTROPHIL COUNT DECREASED 83 0.0020
937 SKIN IRRITATION 93 0.0020
938 STOMATITIS 122 0.0020
939 WHITE BLOOD CELL COUNT DECREASED 217 0.0020
940 RESPIRATORY ARREST 55 0.0020
941 PLASMA CELL MYELOMA 77 0.0020
942 FEAR 53 0.0020
943 DISEASE PROGRESSION 232 0.0020
944 INJECTION SITE RASH 60 0.0020
945 AGGRESSION 97 0.0019
946 NEUTROPENIA 263 0.0019
947 PRODUCT DOSE OMISSION 126 0.0019
948 MUSCULOSKELETAL PAIN 100 0.0019
949 VISUAL ACUITY REDUCED 63 0.0019
950 GASTRIC CANCER 48 0.0019
951 ANGER 63 0.0019
952 MALIGNANT NEOPLASM PROGRESSION 189 0.0018
953 INJECTION SITE ERYTHEMA 227 0.0018
954 IRRITABILITY 109 0.0018
955 PRODUCT STORAGE ERROR 158 0.0018
956 UNEVALUABLE EVENT 135 0.0018
957 THERAPEUTIC RESPONSE DECREASED 108 0.0018
958 SUICIDE ATTEMPT 105 0.0017
959 BREAST CANCER 160 0.0017
960 ANHEDONIA 45 0.0017
961 PROSTATE CANCER 137 0.0017
962 PRODUCT SUBSTITUTION ISSUE 98 0.0017
963 AGITATION 123 0.0017
964 DERMATITIS ATOPIC 86 0.0016
965 OVERDOSE 349 0.0016
966 ACNE 118 0.0016
967 MYELOSUPPRESSION 55 0.0015
968 GYNAECOMASTIA 47 0.0015
969 LEUKOPENIA 71 0.0014
970 ADVERSE EVENT 130 0.0014
971 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 77 0.0014
972 DEVICE USE ERROR 47 0.0014
973 RENAL CANCER 64 0.0013
974 TREATMENT FAILURE 105 0.0013
975 DEVICE DIFFICULT TO USE 82 0.0012
976 MULTIPLE SCLEROSIS 56 0.0012
977 INJURY 82 0.0012
978 ABNORMAL BEHAVIOUR 45 0.0011
979 NO ADVERSE EVENT 202 0.0011
980 PRODUCT QUALITY ISSUE 150 0.0011
981 SKIN BURNING SENSATION 78 0.0011
982 DRUG ABUSE 88 0.0011
983 DRUG DOSE OMISSION BY DEVICE 79 0.0010
984 EMOTIONAL DISTRESS 119 0.0010
985 MATERNAL EXPOSURE DURING PREGNANCY 87 0.0010
986 INJECTION SITE REACTION 67 0.0010
987 ACCIDENTAL EXPOSURE TO PRODUCT 100 0.0010
988 FOETAL EXPOSURE DURING PREGNANCY 71 0.0009
989 COMPLETED SUICIDE 71 0.0009
990 DRUG DOSE OMISSION 79 0.0005
991 DRUG DEPENDENCE 66 0.0004